Benzinga | Sep 29, 2021 01:48PM EDT

AlloVir Earlier Granted FDA Orpha Drug Status For 'Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpes virus-6, Epstein Barr virus, and adenovirus'

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=747920